Anticancer agent 220
Anticancer agent 220 is a chromanone derivative with anticancer effects. Anticancer agent 220 shows highly potent activity in the colon cancer cell lines. Anticancer agent 220 induces apoptosis and cell cycle arrest in cells[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-220.html
Smiles
COC(C1=C(OC(C)=CC1=O)C=C2OCC(OCC)=O)=C2/C=N/NC3=C(Cl)C=C(Cl)C=C3Cl
Molecular Formula
C22H19Cl3N2O6
Molecular Weight
513.76
References & Citations
[1]Heba M Abo-Salem, et al. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity. Sci Rep. 2024 Apr 26;14 (1) :9636.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NDA80787-01 50 mg
5- (2-Methoxyphenyl) -5-methylimidazolidine-2,4-dione
Sign In for Pricing
View Details NDA80787-02 0.5 g
5- (2-Methoxyphenyl) -5-methylimidazolidine-2,4-dione
Sign In for Pricing
View Details 385019 100 µg
GAPDH (CDABP0047, GAPD, GAPDH, OK/SW-cl.12, Peptidyl-Cysteine S-Nitrosylase GAPDH, Glyceraldehyde-3-Phosphate Dehydrogenase) discontinued
Sign In for Pricing
View Details 